Llegonas, Tarcela A.
HRN: 22-35-96 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2022
CEFTAZIDIME 1GM (VIAL)
12/28/2022
01/03/2023
IV
2g
Q8
NKA
Waiting Final Action